SRSF10 facilitates HCC growth and metastasis by suppressing CD8+T cell infiltration and targeting SRSF10 enhances anti-PD-L1 therapy-Reference-Cited by-同舟云学术

SRSF10 facilitates HCC growth and metastasis by suppressing CD8+T cell infiltration and targeting SRSF10 enhances anti-PD-L1 therapy

Published:2024-01 Issue: Volume:127 Page:111376
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Luo Xiangyuan,Zhang Zerui,Li Siwen,Wang Yijun,Sun Mengyu,Hu Dian,Jiang Junqing,Wang Yufei,Ji Xiaoyu,Chen Xiaoping,Zhang Bixiang,Liang Huifang,Li Yiwei,Liu Bifeng,Xu Xiao,Wang Shuai,Xu Shengjun,Nie Yongzhan,Wu Kaichun,Fan Daiming,Liu Danfei^ORCID,Huang Wenjie^ORCID,Xia Limin^ORCID

Funder

National Natural Science Foundation of China

Huazhong University of Science and Technology

Hebei Provincial Natural Science Foundation

Natural Science Foundation of Hubei Province

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference47 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J. Clin.,2021

2. Age independent survival benefit for patients with hepatocellular carcinoma (HCC) without metastases at diagnosis: a population-based study;De Toni;Gut,2020

3. Alternative isoform regulation in human tissue transcriptomes;Wang;Nature,2008

4. RNA splicing dysregulation and the hallmarks of cancer;Bradley;Nat. Rev. Cancer,2023

5. Posttranslational Regulation of the Exon Skipping Machinery Controls Aberrant Splicing in Leukemia;Zhou;Cancer Discov.,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The anticancer potential of the CLK kinases inhibitors 1C8 and GPS167 revealed by their impact on the epithelial-mesenchymal transition and the antiviral immune response;Oncotarget;2024-05-16